Navigation Links
PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
Date:9/12/2013

NEW YORK, Sept. 12, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022

http://www.reportlinker.com/p01622980/PharmaPoint-Non-Small-Cell-Lung-Cancer---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022

Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients with specific biomarkers has begun to fragment the NSCLC treatment landscape into smaller niche patient populations. Over the forecast period, this trend will continue with the launch of multiple new drugs in several new drug classes to address the high unmet need among NSCLC patients, and provide new treatment options for previously underserved populations. Launch of premium-priced drug candidates combined with increasing incident cases of the disease will be major drivers of growth in the major markets.

The Indian NSCLC market has been especially difficult for drug companies to penetrate, and the market revolves almost exclusively around generics. The market is dominated by generic chemotherapies including pemetrexed (Alimta) as well as the generic targeted therapies erlotinib (Tarceva) and gefitinib (Iressa).

Scope

- Overview of NSCLC including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
4. PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
5. PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022
6. PharmaPoint: Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2022
7. Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival
8. Varian Medical Systems to Support an NCI-Sponsored Phase III Study Comparing Radiosurgery with Surgery for the Treatment of Early-Stage High-Risk, Operable Non-Small Cell Lung Cancer
9. Patient Advocate Foundation Receives Significant Support to Aid Non-Squamous Non-Small Cell Lung Cancer Patients through the Co-Pay Relief Program
10. The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
11. NewLink Genetics Presents Positive Phase 2 Data on Novel Immunotherapy, Tergenpumatucel-L, in Non-Small Cell Lung Cancer at the ASCO 2013 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ( ... "Inhaled Drug Delivery (London, UK - November 19-20, 2015)" ... Drug Delivery meeting will cover industry case studies, regulatory ... The Co-Chairmen are Dr Steven Nichols , OINP ... Mylan. Companies participating include: ...
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015 ... the addition of the "An Introduction to ... - November 2-3, 2015)" conference to their ... a comprehensive introduction to the regulations and requirements ... will be highly interactive, using real life examples ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/r6wspz/drug_delivery_in ) has ... "Drug Delivery in Central Nervous System Diseases ... offering. Advances in understanding of ... new avenues and possibilities for improved drug delivery ... enzymes, and receptors that control the penetration of ...
Breaking Medicine Technology:An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 3
... Approval of the 5-1 Stock... -- JERUSALEM, September 16, 2010 ... ... ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for ...
... Safety in Austrian Psychiatric Hospital -- RESTON, Virginia, September 16, 2010 ... ... --> ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. for ...
Cached Medicine Technology:Medisafe 1 Technologies Corp Notify Shareholders on FINRA's Approval of the 5-1 Stock Dividend 2Medisafe 1 Technologies Corp Notify Shareholders on FINRA's Approval of the 5-1 Stock Dividend 3Medisafe 1 Technologies Corp Notify Shareholders on FINRA's Approval of the 5-1 Stock Dividend 4Medisafe 1 Technologies Corp Notify Shareholders on FINRA's Approval of the 5-1 Stock Dividend 5Medisafe 1 Technologies Corp Notify Shareholders on FINRA's Approval of the 5-1 Stock Dividend 6Medisafe 1 Technologies Corp Notify Shareholders on FINRA's Approval of the 5-1 Stock Dividend 7Ekahau RTLS Enables Improvements in Staff Safety in Austrian Psychiatric Hospital 2Ekahau RTLS Enables Improvements in Staff Safety in Austrian Psychiatric Hospital 3Ekahau RTLS Enables Improvements in Staff Safety in Austrian Psychiatric Hospital 4Ekahau RTLS Enables Improvements in Staff Safety in Austrian Psychiatric Hospital 5Ekahau RTLS Enables Improvements in Staff Safety in Austrian Psychiatric Hospital 6Ekahau RTLS Enables Improvements in Staff Safety in Austrian Psychiatric Hospital 7Ekahau RTLS Enables Improvements in Staff Safety in Austrian Psychiatric Hospital 8
(Date:9/3/2015)... , ... September 03, 2015 , ... At Renew Man™, ... dissatisfied with the traditional health care model, where the primary care physician dictates and ... who want to become educated about their health issues and empowered to choose their ...
(Date:9/3/2015)... , ... September 03, 2015 , ... Local filmmakers and ... Hannah & Michael Habernig from Path 11 Productions have had great success in launching ... podcast has featured Hay House authors, Teal Swan who is the well known Spiritual ...
(Date:9/3/2015)... ... September 03, 2015 , ... Doctor Kayode Sotonwa ... health professionals out there. His perspective on internal medicine keeps patients happy and healthy, ... healthy is important regardless of the season, but even more so in the fall, ...
(Date:9/2/2015)... ... September 03, 2015 , ... The Aspen Clinic (TAC), ... retreats geared towards kick-starting and inspiring wellness in the Roaring Fork Valley and beyond. ... developing a whole mind-body approach to fitness - we are much more than a ...
(Date:9/2/2015)... , ... September 03, 2015 , ... ... Johns Hopkins University Bloomberg School of Public Health and an internationally recognized scholar ... Fellows program for 2015-16. Dr. Bleich, a Baltimore native and 1996 graduate of ...
Breaking Medicine News(10 mins):Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 3Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2Health News:TAC Introduces New Retreats for Fall Fitness 2Health News:Dr. Sara Bleich, Garrison Forest Graduate, Selected for 2015-16 Class of White House Fellows 2
... that the people of India constitute more than ... been underrepresented in studies related //to genetic diseases. ... diseases associated with urban and western lifestyles have ... association studies of particular importance. ,In ...
... comparing the safety, effectiveness and reliability of LASIK and LASEK ... of laser eye// surgery. ,The study, led by ... the December 2006 issue of the American Journal of Ophthalmology. ... safety and efficacy of both types of laser surgery, there ...
... Biology, members of Dr. John Herr’s laboratory at the ... a new protein within a sperm’s tail that could ... ,“There’s considerable interest in developing new male contraceptives,” ... Contraceptive and Reproductive Health. “To support this effort, our ...
... somehow delay the greying process continues with gusto into the ... Youthfulness always pouts with tantalising// appeal. The latest from scientists ... If the DNA within a living cell gets damaged, it ... especially true if the cell is too weak to help ...
... the repercussions of a potential flu pandemic showed that nearly ... nations, could pay// with their life. , ,The ... Spanish flu, which wiped out nearly 20 million people in ... Health and the University of Queensland studied the data gathered ...
... Researcher predict that in the years ahead, medical science ... transform medicine for various treatments will stand to// reshape ... dean of the health-planning department at Eastern Virginia Medical ... based on these technologies. ,'Fat Fryer' Device ...
Cached Medicine News:Health News:Researchers Make Progress in Studying Genetic Traits of India-born Populations 2Health News:Study Compares LASIK and LASEK Eye Surgery 2Health News:Male Contraception: Discovery Stirring Interest Among Scientists, Drug Developers 2Health News:Clues to Allay Aging 2Health News:Medical Science Miracles – Coming Your Wa 2